Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

95
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
95
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

185
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
185
Chronopharmacokinetics: Time-Dependent Pharmacokinetics01:20

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

344
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
344
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

285
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
285
Community Based Intervention01:30

Community Based Intervention

226
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
226
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

606
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
606

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Consumer preferences for pharmacist- and GP-led diagnostic and prescribing professional services: a discrete choice experiment in Australia.

The International journal of pharmacy practice·2026
Same author

Public Health Service Clinical Journeys of Patients With Primary Substance Use Disorders Who Are Subsequently Diagnosed With Non-Affective Psychotic Disorders.

Early intervention in psychiatry·2026
Same author

Barriers and facilitators to sexual and reproductive health services among adolescents and young adults in Sidama region, Ethiopia: a qualitative study.

Reproductive health·2026
Same author

Point-of-care testing in community pharmacies to improve antimicrobial stewardship in respiratory infections: a scoping review of effectiveness, implementation and cost-effectiveness.

JAC-antimicrobial resistance·2026
Same author

PROTOCOL: The Value of Rural Provider-To-Provider Telehealth for Emergency and Inpatient Care: An Evidence and Gap Map.

Campbell systematic reviews·2026
Same author

<i>The Safer Spaces Project</i>: a whole of community systems approach to co-designing and implementing a 'Safer Spaces' model of primary healthcare for LGBTQ+ young people in Western Victoria - a protocol for a mixed-methods study.

BMJ open·2026
Same journal

Assessing confidence of community pharmacists in inflammatory bowel disease management: a cross-sectional study in Malta.

The International journal of pharmacy practice·2026
Same journal

Pharmacist-led communication strategies using social norm nudging and numerical information: a randomized field study on the willingness of Japanese patients to initiate treatment.

The International journal of pharmacy practice·2026
Same journal

Mapping the international research on pharmacists' prescribing to initiate medications: a scoping review.

The International journal of pharmacy practice·2026
Same journal

Managing medicine shortages in community pharmacies: a simulated patient mixed-method study.

The International journal of pharmacy practice·2026
Same journal

Pharmacist prioritization tools for paediatric patients: development, implementation, validation, and impact-a systematic review.

The International journal of pharmacy practice·2026
See all related articles

Related Experiment Video

Updated: Dec 23, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.3K

Community pharmacist workflow: Space for Pharmacy-based Interventions and Consultation TimE study protocol.

Ajay Mahendrarai Karia1, Christine Balane2, Richard Norman1

  • 1School of Public Health, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.

The International Journal of Pharmacy Practice
|April 30, 2020
PubMed
Summary
This summary is machine-generated.

This study used time and motion methods to assess Australian pharmacists

Keywords:
community pharmacyobservation studyprimary careprofessional practicetime and motion study

More Related Videos

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.7K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.4K

Related Experiment Videos

Last Updated: Dec 23, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.3K
Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.7K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.4K

Area of Science:

  • Pharmacy Practice Research
  • Health Services Research
  • Workforce Capacity Studies

Background:

  • Pharmacists' roles are expanding to include medication management, vaccinations, and screening.
  • Limited research exists on Australian community pharmacists' capacity for expanded services.
  • This study protocol addresses this gap by investigating workload capacity.

Purpose of the Study:

  • To investigate the variation in pharmacists' daily tasks and workspace.
  • To measure workload capacity for expanding pharmacy services in Australian community pharmacies.
  • To provide quantitative evidence on pharmacists' time and work setting.

Main Methods:

  • Observational time and motion study in up to 20 Australian community pharmacies.
  • Data collection using the electronic Work Observation Method By Activity Timing (WOMBAT) tool.
  • Analysis of task duration, multitasking, interruptions, and workspace environment, including heat-mapped floor plans.

Main Results:

  • This section is not available in the provided abstract.
  • This section is not available in the provided abstract.
  • This section is not available in the provided abstract.

Conclusions:

  • Pharmacists can potentially alleviate strained health systems.
  • Novel time and motion methodology will enhance understanding of Australian community pharmacy practice.
  • Findings will inform pharmacists' capacity and optimize their work environment.